Advertisement
Research Article

Antibody to the Filarial Antigen Wb123 Reflects Reduced Transmission and Decreased Exposure in Children Born following Single Mass Drug Administration (MDA)

  • Cathy Steel mail,

    csteel@niaid.nih.gov

    Affiliation: Laboratory of Parasitic Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Joseph Kubofcik,

    Affiliation: Laboratory of Parasitic Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Eric A. Ottesen,

    Affiliation: Lymphatic Filariasis Support Center, The Task Force for Global Health, Decatur, Georgia, United States of America

    X
  • Thomas B. Nutman

    Affiliation: Laboratory of Parasitic Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Published: December 06, 2012
  • DOI: 10.1371/journal.pntd.0001940

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Longitudinal Monitoring of the Development of Antifilarial Antibodies and Acquisition of Wuchereria bancrofti in a Highly Endemic Area of Haiti

Katy L. Hamlin, Delynn M. Moss, Jeffrey W. Priest, Jacquelin Roberts, Joseph Kubofcik, Katherine Gass, Thomas G. Streit, Thomas B. Nutman, Mark L. Eberhard, Patrick J. Lammie
Research Article | published 6 Dec 2012 | PLOS Neglected Tropical Diseases
doi:10.1371/journal.pntd.0001941

Identification of Wb123 as an Early and Specific Marker of Wuchereria bancrofti Infection

Joseph Kubofcik, Doran L. Fink, Thomas B. Nutman
Research Article | published 6 Dec 2012 | PLOS Neglected Tropical Diseases
doi:10.1371/journal.pntd.0001930